Synthetic microbes as drug delivery systems
- PMID: 25079685
- PMCID: PMC4410909
- DOI: 10.1021/sb500258b
Synthetic microbes as drug delivery systems
Abstract
Synthetic cell therapy is a field that has broad potential for future applications in human disease treatment. Next generation therapies will consist of engineered bacterial strains capable of diagnosing disease, producing and delivering therapeutics, and controlling their numbers to meet containment and safety concerns. A thorough understanding of the microbial ecology of the human body and the interaction of the microbes with the immune system will benefit the choice of an appropriate chassis that engrafts stably and interacts productively with the resident community in specific body niches.
Keywords: bacterial therapeutic; biosafety; delivery; diagnosis; human microbiome; signal integration.
Figures
References
-
- Xie Z.; Wroblewska L.; Prochazka L.; Weiss R.; Benenson Y. (2011) Multi-Input RNAi-Based Logic Circuit for Identification of Specific Cancer Cells. Science 333, 1307–1311. - PubMed
-
- Hamady Z. Z. R.; Scott N.; Farrar M. D.; Lodge J. P. A.; Holland K. T.; Whitehead T.; Carding S. R. (2010) Xylan-regulated delivery of human keratinocyte growth factor-2 to the inflamed colon by the human anaerobic commensal bacterium Bacteroides ovatus. Gut 59, 461–469. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
